Market Place
Sourcing Support
All News #Library
Biotech
Telomir Pharma Induces Broad Tumor Death in Human TNBC Models
17 Feb 2026 //
PHARMIWEB
Telomir Pharma Unveils Data Backing Epigenetic Cancer, Aging Link
05 Feb 2026 //
PHARMIWEB
Telomir Pharma Reports Telomir-1 Slashes Tumor Growth
05 Jan 2026 //
PHARMIWEB
Telomir Pharma Reports Favorable IND Safety for Telomir-1
18 Dec 2025 //
PHARMIWEB
Telomir Pharma Reveals Telomir-1 Reduces PSA In Prostate Cancer
25 Nov 2025 //
PHARMIWEB
Telomir Pharma Reveals Telomir-1 Eradicates Aggressive Leukemia
21 Nov 2025 //
PHARMIWEB
Telomir-1 Beats DFO in Cutting Intracellular Iron Levels
12 Nov 2025 //
PHARMIWEB
Telomir Pharma Unveils Telomir-1`s Superiority Over Rapamycin
23 Oct 2025 //
PHARMIWEB
Telomir Data Shows Telomir-1 Kills Aggressive Pancreatic Cancer
14 Oct 2025 //
PHARMIWEB
Telomir-1 Shown to Kill Aggressive Triple-Negative Breast Cancer
09 Oct 2025 //
PHARMIWEB
Telomir Finds Telomir-1 Resets DNA Methylation In Prostate Cancer
07 Oct 2025 //
PHARMIWEB
Telomir Reveals Telomir-1 Resets DNA, Outperforms Rapamycin
09 Sep 2025 //
ACCESSWIRE
Telomir Pharmaceuticals Shows Telomir-1`s Promise in Influencing
28 Aug 2025 //
PHARMAWEB
Telomir Pharmaceuticals Unveils Telomir-1`s Unique Profile
24 Jul 2025 //
ACCESSWIRE
Telomir-1 Reverses Gene Silencing in Prostate Cancer, Beats Chemo
18 Jul 2025 //
ACCESSWIRE
Telomir-1 Reverses DNA Aging in Werner Syndrome Animal Model
05 Jun 2025 //
PHARMAWEB
Telomir Unveils Compelling Pre-Clinical Data on Age-Reversal Drug Telomir-1
16 Apr 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.